LXG.V - LexaGene Holdings Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 570.26M
Enterprise Value 369.71M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)58.57
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.21

Trading Information

Stock Price History

Beta (5Y Monthly) 2.44
52-Week Change 322.39%
S&P500 52-Week Change 310.64%
52 Week High 31.0000
52 Week Low 30.4300
50-Day Moving Average 30.7917
200-Day Moving Average 30.7197

Share Statistics

Avg Vol (3 month) 3218.41k
Avg Vol (10 day) 3224.47k
Shares Outstanding 585.69M
Float 75.24M
% Held by Insiders 115.54%
% Held by Institutions 10.40%
Shares Short (May 14, 2020) 4197.05k
Short Ratio (May 14, 2020) 41.41
Short % of Float (May 14, 2020) 4N/A
Short % of Shares Outstanding (May 14, 2020) 40.23%
Shares Short (prior month Apr. 14, 2020) 4142.87k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Feb. 27, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Feb. 27, 2019
Most Recent Quarter (mrq)Nov. 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-109.54%
Return on Equity (ttm)-257.00%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.57M
Net Income Avi to Common (ttm)-7.99M
Diluted EPS (ttm)-0.1130
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.84M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)1.88M
Total Debt/Equity (mrq)51.35
Current Ratio (mrq)14.22
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-5.92M
Levered Free Cash Flow (ttm)-2.98M